These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30144500)

  • 1. MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1.
    Ke SB; Qiu H; Chen JM; Shi W; Chen YS
    Gene; 2018 Nov; 676():329-335. PubMed ID: 30144500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
    Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
    Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC).
    Zhang T; Cai X; Li Q; Xue P; Chen Z; Dong X; Xue Y
    Oncotarget; 2016 Jul; 7(27):42225-42240. PubMed ID: 27302926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.
    Zhang X; Zhang Y; Yang J; Li S; Chen J
    Cancer Gene Ther; 2015 Oct; 22(10):475-80. PubMed ID: 26384136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.
    Li Q; Liang X; Wang Y; Meng X; Xu Y; Cai S; Wang Z; Liu J; Cai G
    Sci Rep; 2016 May; 6():27157. PubMed ID: 27244080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-140-5p inhibits the progression of colorectal cancer by targeting VEGFA.
    Zhang W; Zou C; Pan L; Xu Y; Qi W; Ma G; Hou Y; Jiang P
    Cell Physiol Biochem; 2015; 37(3):1123-33. PubMed ID: 26402430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.
    Huang LX; Hu CY; Jing L; Wang MC; Xu M; Wang J; Wang Y; Nan KJ; Wang SH
    Cancer Sci; 2017 Oct; 108(10):1985-1995. PubMed ID: 28771881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
    Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
    J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-19-5p Enhances Tumorigenesis in Human Colorectal Cancer Cells by Targeting TSPYL5.
    Huang C; Luo H
    DNA Cell Biol; 2018 Jan; 37(1):23-30. PubMed ID: 29240449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
    Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-511-5p functions as a tumor suppressor and a predictive of prognosis in colorectal cancer by directly targeting GPR116.
    Wang C; Fan HQ; Zhang YW
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6119-6130. PubMed ID: 31364112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT2, a direct target of miR-212-5p, suppresses the proliferation and metastasis of colorectal cancer cells.
    Du F; Li Z; Zhang G; Shaoyan S; Geng D; Tao Z; Qiu K; Liu S; Zhou Y; Zhang Y; Gu J; Wang G; Li L; Wu W
    J Cell Mol Med; 2020 Sep; 24(17):9985-9998. PubMed ID: 32697380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
    J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced microRNA-590-5p promotes colorectal cancer progression by modulating matrix metalloproteinase activity.
    Kim CW; Oh ET; Kim JM; Park JS; Lee DH; Lee JS; Kim KK; Park HJ
    Cancer Lett; 2018 Mar; 416():31-41. PubMed ID: 29247825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR-942-5p and releasing DLG2 via Hippo-YAP signaling.
    Li S; Yan G; Liu W; Li C; Wang X
    Mol Carcinog; 2020 Dec; 59(12):1323-1342. PubMed ID: 33128289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis.
    Liu S; Xiao Z; Ai F; Liu F; Chen X; Cao K; Ren W; Zhang X; Shu P; Zhang D
    Biomed Pharmacother; 2017 Aug; 92():1119-1127. PubMed ID: 28622713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
    Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.